glp-1 thyroid Receptor Agonists and Cancer Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid Study: GLP-1 drugs don't increase

As prescriptions increased, patients and clinicians began reporting a wider range of adverse effects beyond those described in early clinical trials

About a dozen states have opted to participate

An animal model of glutathione depletion demonstrated a significant increase in oxidative stress during exercise

Important safety precautions include performing an allergy test before the first treatment, avoiding injection into muscle tissue or blood vessels, and monitoring for asymmetric swelling exceeding 7 days

Men are less likely to develop insulin resistance in the presence of low insulin-like growth factor-1 levels